When analyzing each drug separately, the effect of PBRM1 expression was stronger in patients treated with everolimus (median PFS in low and high PBRM1 expression groups was 3.0 months and 1.9 months, respectively; p = 0.10) although it did not reach statistical significance.
← all excerpts
Prognostic and Predictive Value of <i>PBRM1</i> in Clear Cell Renal Cell Carcinoma.
1
—
—